Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04454203 · ClinicalTrials.gov registry record · Phase 4

Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension

A Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty, sponsored by Duke University.

Recruiting
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT04454203 is a Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty that is actively recruiting participants, run by Duke University. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04454203, a Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time.

Interventions

  • DRUG Saline
  • DRUG Mepivacaine
  • PROCEDURE Perifemoral Injection of Local Anesthetic

Study Locations (1)

North Carolina

  • Duke University Hospital - Durham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-02-05
Est. Completion 2027-02-03
Phase Phase 4

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04454203

The ClinicalTrials.gov registry entry for NCT04454203 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Intraoperative Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.

NCT04454203 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04454203 about?

NCT04454203 is a clinical study titled "Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension". The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time...

What is the current status of trial NCT04454203?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2021-02-05. Estimated completion is 2027-02-03.

What conditions does trial NCT04454203 study?

This clinical trial studies the following conditions: Intraoperative Hypertension, Total Ankle Arthroplasty, Ankle Fusion, Tourniquet Hypertension.

What interventions are being tested in trial NCT04454203?

The interventions under investigation include: Saline (DRUG), Mepivacaine (DRUG), Perifemoral Injection of Local Anesthetic (PROCEDURE).

Who is sponsoring clinical trial NCT04454203?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04454203 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intraoperative Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.